Video tutorial on injection method of elastran

Many people mistakenly believe that elacestrant is an injection form like traditional SERD drugs, but this is not the case. As the world's first oral SERD drug approved by the FDA, Elacestrant is available as a film-coated tablet instead of an injection or intramuscular injection. Therefore, there is currently no "video tutorial on elastran injection", and the relevant guidance should focus on the correct use of its oral form.

The main indication of ORSERDU is the treatment of breast cancer. The recommended dose is 345 mg per day and the tablet must be swallowed whole with food. Food can not only improve the bioavailability of drugs, but also effectively reduce common adverse reactions such as nausea, bloating, and loss of appetite after taking drugs. The type of food should be light, high in protein, and easy to digest. Avoid high-fat diet or spicy food that may increase the burden on the gastrointestinal tract.

When taking the medicine, the patient must swallow the tablet whole and do not break it, crush it or chew it. Because the coating design of the tablet helps the drug to be released accurately in the intestine, once the coating is damaged, it may lead to reduced efficacy or increased toxicity. Any cracked, broken, or wet tablets should be discarded.

In addition, if the patient vomits within a short period of time after taking the medicine or misses the medicine for more than six hours, it is recommended to skip the dose directly and do not try to take it again to avoid overdose or drug accumulation. The next dose should be taken on time the next day. During long-term medication, it is recommended to cooperate with your doctor to regularly monitor liver function, bone density and blood indicators to ensure safety.

Although there is currently no official video tutorial, patients can learn more specific medication operation videos and precautions through ORSERDU’s official information, medication guidance provided by doctors, or professional medical service platforms. As global awareness of oral SERD increases, relevant training resources will become more popular in the future.

Reference materials：https://www.drugs.com/mtm/elacestrant.html